Topoisomerases inhibition and DNA binding mode of daunomycin-oligoarginine conjugate
Cancer is a major health issue adsorbing the attention of a biomedical research. To fight this disease, new drugs are developed, specifically tailored to target biological pathways or peculiar components of the tumour cells. Particularly interesting is the use of intercalating agents as drugs capabl...
Saved in:
Main Authors: | Valeria Visone (Author), Ildikó Szabó (Author), Giuseppe Perugino (Author), Ferenc Hudecz (Author), Zoltán Bánóczi (Author), Anna Valenti (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing Cell Penetration Efficiency of Cyclic Oligoarginines Using Rigid Scaffolds
by: Csaba Bató, et al.
Published: (2023) -
Oligoarginine Peptide Conjugated to BSA Improves Cell Penetration of Gold Nanorods and Nanoprisms for Biomedical Applications
by: Karen Bolaños, et al.
Published: (2021) -
Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer
by: Levente E. Dókus, et al.
Published: (2020) -
The Balance between Hydrophobicity/Aromaticity and Positively Charged Residues May Influence the Cell Penetration Ability
by: Dóra Soltész, et al.
Published: (2023) -
The Potential of Topoisomerase Inhibitor-Based Antibody-Drug Conjugates
by: Seungmin Han, et al.
Published: (2022)